Radioactive iodine therapy in poorly differentiated thyroid cancer

被引：11
|
作者：
Tuttle, R. Michael
Grewal, Ravinder K.
Larson, Steve M.
机构：
[1] Mem Sloan Kettering Canc Ctr, Serv Endocrinol, Dept Med, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Mem Hosp,Dept Radiol, Laurent & Alberta Gerschel Positron Emmiss Tomog, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Ludwig Trust Ctr Immunotherapy, New York, NY 10021 USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2007年 / 4卷 / 11期
关键词：
dosimetry; radioactive iodine therapy; thyroid cancer;
D O I：
10.1038/ncponc0979
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: A 55-year-old male was diagnosed with poorly differentiated thyroid cancer after total thyroidectomy, which was performed because of progressive enlargement of a dominant thyroid nodule. He developed an early cervical recurrence that was treated with modified neck dissection. He subsequently developed biopsy-proven progressive pulmonary metastases. Investigations: Neck and chest CT scans, laboratory tests, CT-guided fine-needle aspiration biopsy, [F-18]-2-fluoro-2-deoxy-D-glucose-PET scan, lesional dosimetry using 1241 PET scan, diagnostic radioactive iodine (RAI) scanning, whole-body and blood RAI dosimetry, and single-photon-emission CT. Diagnosis: Stage IV poorly differentiated thyroid cancer. Management: Surgical resection of cervical recurrence, RAI therapy.
引用
收藏
页码：665 / 668
页数：4
相关论文
共 50 条
  • [1] Radioactive iodine therapy in poorly differentiated thyroid cancer
    R Michael Tuttle
    Ravinder K Grewal
    Steve M Larson
    [J]. Nature Clinical Practice Oncology, 2007, 4 : 665 - 668
  • [2] Perspective: The Molecular Landscape of Radioactive Iodine Refractory Differentiated Thyroid Cancer and Poorly Differentiated Thyroid Cancer
    Shobab, Leila
    Wartofsky, Leonard
    [J]. THYROID, 2023, 33 (02) : 138 - 142
  • [3] Radioactive iodine (RAI) therapy for metastatic differentiated thyroid cancer
    Verburg, Frederik A.
    Haenscheid, Heribert
    Luster, Markus
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 279 - 290
  • [4] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: 2020 Update
    Ciarallo, Anthony
    Rivera, Juan
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (02) : 285 - 291
  • [5] Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
    Liu, Jierui
    Liu, Yanqing
    Lin, Yansong
    Liang, Jun
    [J]. ENDOCRINOLOGY AND METABOLISM, 2019, 34 (03) : 215 - 225
  • [6] Variable response to radioactive iodine treatment in poorly differentiated thyroid carcinoma
    Underwood, Hunter J.
    Shaha, Ashok R.
    Patel, Kepal N.
    [J]. GLAND SURGERY, 2019, 8 (06) : 589 - 590
  • [7] Severe Hyponatremia Following Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
    Kim, Seung Kyu
    Yun, Gi Young
    Kim, Ki Hyun
    Park, Seung Kyo
    Choi, Hoon Young
    Ha, Sung Kyu
    Park, Hyeong Cheon
    [J]. THYROID, 2014, 24 (04) : 773 - 777
  • [8] Factors Associated with Dose Determination of Radioactive Iodine Therapy for Differentiated Thyroid Cancer
    Hong C.M.
    Ahn B.-C.
    [J]. Nuclear Medicine and Molecular Imaging, 2018, 52 (4) : 247 - 253
  • [9] Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer
    Wang, Sen
    Liang, Chao
    Zhao, Li
    Meng, Zhaowei
    Zhang, Chunmei
    Jia, Qiang
    Tan, Jian
    Yang, Hui
    Liu, Xiangxiang
    Wang, Xiaoran
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1113 - 1120
  • [10] Experiences of low iodine diets in the treatment of differentiated thyroid cancer with radioactive iodine ablation therapy
    Herbert, Georgia
    Searle, Aidan
    England, Clare Yvonne
    Ness, Andy
    Beasley, Matthew
    Haupt-Schott, Ingrid
    Moss, Laura
    Wescott, Judith
    Atkinson, Charlotte
    [J]. CLINICAL NUTRITION ESPEN, 2020, 39 : 190 - 197
12345